Is the failing heart energy starved? On using chemical energy to support cardiac function.

The requirement of chemical energy in the form of ATP to support systolic and diastolic work of the heart is absolute. Because of its central role in cardiac metabolism and performance, the subject of this review on energetics in the failing heart is ATP. We briefly review the basics of myocardial ATP metabolism and describe how this changes in the failing heart. We present an analysis of what is now known about the causes and consequences of these energetic changes and conclude by commenting on unsolved problems and opportunities for future basic and clinical research.

[1]  G. Shulman,et al.  AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Stefan Neubauer,et al.  Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. , 2002, Journal of the American College of Cardiology.

[3]  T. Hornemann,et al.  Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology , 1998, BioFactors.

[4]  V. Veksler,et al.  From energy store to energy flux: a study in creatine kinase deficient fast skeletal muscle , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  J. Seidman,et al.  Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. , 1998, The Journal of clinical investigation.

[6]  K. Swedberg,et al.  Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy , 1993, The Lancet.

[7]  R. Tian.  Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart , 2003, Current hypertension reports.

[8]  H. Suga.  Cardiac Energetics: From Emax to Pressure-Volume Area , 2013, Developments in Cardiovascular Medicine.

[9]  L. Goodyear,et al.  Increased Adenosine Monophosphate–Activated Protein Kinase Activity in Rat Hearts With Pressure-Overload Hypertrophy , 2001, Circulation.

[10]  J. Zweier,et al.  Bioenergetic consequences of cardiac phosphocreatine depletion induced by creatine analogue feeding. , 1991, The Journal of biological chemistry.

[11]  V. P. Chacko,et al.  Preservation of glucose metabolism in hypertrophic GLUT4-null hearts. , 2000, American journal of physiology. Heart and circulatory physiology.

[12]  D. Kass,et al.  What Mechanisms Underlie Diastolic Dysfunction in Heart Failure? , 2004, Circulation research.

[13]  A. Składanowski,et al.  Partial purification and properties of an AMP-specific soluble 5'-nucleotidase from pigeon heart. , 1990, The Biochemical journal.

[14]  O. Lutz,et al.  Differences in cardiac energetics between patients with familial and nonfamilial hypertrophic cardiomyopathy. , 2000, Circulation.

[15]  H Suga,et al.  Ventricular energetics. , 1990, Physiological reviews.

[16]  A. From,et al.  Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2-deoxyglucose uptake. A 31P NMR spectroscopic study. , 1995, Circulation.

[17]  R. Starling,et al.  Human myocardial ATP content and in vivo contractile function , 1998, Molecular and Cellular Biochemistry.

[18]  Anne H. Soukhanov,et al.  The american heritage dictionary of the english language , 1992 .

[19]  H. Krebs,et al.  A survey of the energy transformations in living matter. , 1957, Ergebnisse der Physiologie, biologischen Chemie und experimentellen Pharmakologie.

[20]  J. Ingwall.  Is cardiac failure a consequence of decreased energy reserve , 1993 .

[21]  G. Lopaschuk,et al.  Energy Metabolism in the Hypertrophied Heart , 2002, Heart Failure Reviews.

[22]  D. Hardie,et al.  The AMP-activated protein kinase--fuel gauge of the mammalian cell? , 1997, European journal of biochemistry.

[23]  A. Blamire,et al.  Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. , 2003, Journal of the American College of Cardiology.

[24]  A. Parmeggiani,et al.  REGULATION OF GLYCOGENOLYSIS IN MUSCLE. II. CONTROL OF GLYCOGEN PHOSPHORYLASE REACTION IN ISOLATED PERFUSED HEART. , 1964, The Journal of biological chemistry.

[25]  L. Arnolda.  Is the failing heart energy-starved? , 1990 .

[26]  J. Halow,et al.  Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart. , 1997, The Journal of clinical investigation.

[27]  Mohit M. Jain,et al.  Cardiac-Specific Overexpression of GLUT1 Prevents the Development of Heart Failure Attributable to Pressure Overload in Mice , 2002, Circulation.

[28]  A. Garnier,et al.  Energy metabolism in heart failure , 2004, The Journal of physiology.

[29]  The AMP‐Activated Protein Kinase , 1997 .

[30]  A. Składanowski,et al.  Distinct Roles for Recombinant Cytosolic 5′-Nucleotidase-I and -II in AMP and IMP Catabolism in COS-7 and H9c2 Rat Myoblast Cell Lines* , 2000, The Journal of Biological Chemistry.

[31]  C. Seidman.  Genetic causes of inherited cardiac hypertrophy: Robert L. Frye Lecture. , 2002, Mayo Clinic proceedings.

[32]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[33]  ICHAEL,et al.  THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE , 2000 .

[34]  A. From,et al.  Myocardial oxygenation during high work states in hearts with postinfarction remodeling. , 1999, Circulation.

[35]  H. Taegtmeyer,et al.  Glycogen Turnover in the Isolated Working Rat Heart (*) , 1995, The Journal of Biological Chemistry.

[36]  J. Ingwall,et al.  Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. , 1996, Journal of molecular and cellular cardiology.

[37]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[38]  J. Ingwall,et al.  Reaction rates of creatine kinase and ATP synthesis in the isolated rat heart. A 31P NMR magnetization transfer study. , 1985, The Journal of biological chemistry.

[39]  S. Bishop,et al.  Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. , 1970, The American journal of physiology.

[40]  C. Sylvén,et al.  Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. , 1995, Cardiovascular research.

[41]  J. Spann,et al.  Defective lipid metabolism in the failing heart. , 1968, The Journal of clinical investigation.

[42]  Ave Minajeva,et al.  Energetic Crosstalk Between Organelles: Architectural Integration of Energy Production and Utilization , 2001, Circulation research.

[43]  C. Apstein.  Glucose-insulin-potassium for acute myocardial infarction: remarkable results from a new prospective, randomized trial. , 1998, Circulation.

[44]  B. Lorell,et al.  Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts. , 1997, Circulation.

[45]  J. Timmerman,et al.  Melanoma vaccines: Prim and proper presentation , 1998, Nature Medicine.

[46]  Jianyi(Jay) Zhang,et al.  Myocardial creatine kinase expression after left ventricular assist device support. , 2002, Journal of the American College of Cardiology.

[47]  C. Hardy,et al.  Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. , 1991, American heart journal.

[48]  F. Shishido,et al.  High-energy phosphate metabolism of the myocardium in normal subjects and patients with various cardiomyopathies--the study using ECG gated MR spectroscopy with a localization technique. , 1992, Japanese circulation journal.

[49]  J. Ingwall,et al.  Acidosis during ischemia promotes adenosine triphosphate resynthesis in postischemic rat heart. In vivo regulation of 5'-nucleotidase. , 1994, The Journal of clinical investigation.

[50]  Fritz Lipmann.  Metabolic Generation and Utilization of Phosphate Bond Energy , 2006 .

[51]  J. Ingwall,et al.  Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. , 1995, Circulation.

[52]  A. Terzic,et al.  Adenylate kinase-catalyzed phosphotransfer in the myocardium : increased contribution in heart failure. , 1999, Circulation research.

[53]  H. Watkins,et al.  Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis. , 2003, Journal of molecular and cellular cardiology.

[54]  Jiandie D. Lin,et al.  Bioenergetic Analysis of Peroxisome Proliferator-activated Receptor γ Coactivators 1α and 1β (PGC-1α and PGC-1β) in Muscle Cells* , 2003, Journal of Biological Chemistry.

[55]  J. Ingwall,et al.  Kinetic, Thermodynamic, and Developmental Consequences of Deleting Creatine Kinase Isoenzymes from the Heart , 2000, The Journal of Biological Chemistry.

[56]  Theo Wallimann,et al.  An increase in the myocardial PCr/ATP ratio in GLUT4 null mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  J. Ingwall,et al.  Inhibition of the creatine kinase reaction decreases the contractile reserve of isolated rat hearts. , 1995, The American journal of physiology.

[58]  Steven R Houser,et al.  Is depressed myocyte contractility centrally involved in heart failure? , 2003, Circulation research.

[59]  G. Shulman,et al.  Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. , 2001, American journal of physiology. Endocrinology and metabolism.

[60]  William C Stanley,et al.  Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-&agr; in Pacing-Induced Heart Failure , 2002, Circulation.

[61]  J. Ingwall,et al.  Regulation of cardiac AMP-specific 5'-nucleotidase during ischemia mediates ATP resynthesis on reflow. , 1998, American journal of physiology. Cell physiology.

[62]  O. Lutz,et al.  31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. , 1998, Circulation.

[63]  J. Hoerter,et al.  Subcellular creatine kinase alterations. Implications in heart failure. , 1999, Circulation research.

[64]  G. Shipley,et al.  Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy , 1998, Nature Medicine.

[65]  I. Momken,et al.  Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles , 2003, The Journal of physiology.

[66]  W. Schwartz,et al.  MYOCARDIAL METABOLISM IN CONGESTIVE HEART FAILURE , 1951, Journal of chronic diseases.

[67]  R. Bache,et al.  Regulation of myocardial blood flow by oxygen consumption is maintained in the failing heart during exercise. , 1999, Circulation research.

[68]  P. Grayburn,et al.  Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. , 1994, Journal of the American College of Cardiology.

[69]  J. Ingwall,et al.  Energetic basis for reduced contractile reserve in isolated rat hearts. , 1996, The American journal of physiology.

[70]  S. Vatner,et al.  Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. , 1999, Circulation.

[71]  William Morris.  The American Heritage dictionary of the English language , 1969 .

[72]  S. Neubauer,et al.  Chronic Phosphocreatine Depletion by the Creatine Analogue &bgr;-Guanidinopropionate Is Associated With Increased Mortality and Loss of ATP in Rats After Myocardial Infarction , 2001, Circulation.

[73]  D. Kelly,et al.  Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. , 1996, Circulation.

[74]  Bertram Pitt,et al.  Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) , 1997, The Lancet.

[75]  S. Neubauer,et al.  Downregulation of the Na(+)-creatine cotransporter in failing human myocardium and in experimental heart failure. , 1999, Circulation.

[76]  J. Ingwall,et al.  Regional changes in creatine kinase and myocyte size in hypertensive and nonhypertensive cardiac hypertrophy. , 1990, Circulation research.

[77]  K Ugurbil,et al.  Myocardial oxygenation at high workstates in hearts with left ventricular hypertrophy. , 1999, Cardiovascular research.

[78]  R S Balaban,et al.  Regulation of oxidative phosphorylation in the mammalian cell. , 1990, The American journal of physiology.

[79]  S. Neubauer,et al.  Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. , 1997, Circulation.

[80]  O. Frazier,et al.  Metabolic Gene Expression in Fetal and Failing Human Heart , 2001, Circulation.

[81]  D. DeMets,et al.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.

[82]  V. Veksler,et al.  Metabolic myopathy in heart failure. , 2002, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[83]  J. Ingwall,et al.  Creatine kinase system in failing and nonfailing human myocardium. , 1996, Circulation.

[84]  Jianyi(Jay) Zhang,et al.  The Molecular Energetics of the Failing Heart from Animal Models—Large Animal Models , 1999, Heart Failure Reviews.

[85]  J. Ingwall,et al.  Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. , 1998, Circulation research.

[86]  P. Puigserver,et al.  A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.

[87]  H. Taegtmeyer.  Metabolism--the lost child of cardiology. , 2000, Journal of the American College of Cardiology.

[88]  J. Ingwall,et al.  Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T. , 2003, The Journal of clinical investigation.

[89]  J. Seidman,et al.  Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. , 2002, The Journal of clinical investigation.

[90]  V. Mootha,et al.  Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 , 1999, Cell.

[91]  S. Morikawa,et al.  Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. , 2003, Journal of the American College of Cardiology.

[92]  Frederick J. Schoen,et al.  A Mouse Model of Familial Hypertrophic Cardiomyopathy , 1996, Science.

[93]  J. Ingwall.  ATP and the Heart , 2002, Basic Science for the Cardiologist.

[94]  E. E. van der Wall,et al.  Cardiac metabolism in patients with dilated and hypertrophic cardio‐myopathy: Assessment with proton‐decoupled P‐31 MR spectroscopy , 1992, Journal of magnetic resonance imaging : JMRI.

[95]  A. Katz,et al.  Is the failing heart energy depleted? , 1998, Cardiology clinics.

[96]  R S Balaban,et al.  Relation between work and phosphate metabolite in the in vivo paced mammalian heart. , 1986, Science.

[97]  Arend Heerschap,et al.  Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement , 2000, The EMBO journal.

[98]  T. DeGrado,et al.  Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure , 2001, Circulation.

[99]  R. Shemin,et al.  The creatine kinase system in normal and diseased human myocardium. , 1985, The New England journal of medicine.

[100]  G. Lopaschuk,et al.  Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. , 1994, The American journal of physiology.

[101]  Jiandie D. Lin,et al.  Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. , 2003, The Journal of biological chemistry.

[102]  D. Kelly,et al.  Gene Regulatory Mechanisms Governing Energy Metabolism during Cardiac Hypertrophic Growth , 2002, Heart Failure Reviews.

[103]  G. Radda,et al.  Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy , 1991, The Lancet.

[104]  J. Ingwall,et al.  The Molecular Energetics of the Failing Heart from Animal Models―Small Animal Models , 1999, Heart Failure Reviews.

[105]  G. J. van der Vusse,et al.  Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? , 2004, Cardiovascular research.

[106]  J. Ingwall,et al.  Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. , 1996, Circulation research.